Bill

Bill > LD1117


ME LD1117

ME LD1117
An Act To Prevent Excessive Prices for Prescription Drugs


summary

Introduced
03/18/2021
In Committee
03/18/2021
Crossed Over
06/15/2021
Passed
06/16/2021
Dead
07/19/2021
Vetoed
07/19/2021
Signed/Enacted/Adopted
06/17/2021

Introduced Session

130th Legislature

Bill Summary

This bill prohibits excessive price increases for generic and off-patent prescription drugs sold in this State. The bill makes prescription drug manufacturers who violate the provisions subject to enforcement action by the Attorney General.

AI Summary

This bill prohibits excessive price increases for generic and off-patent prescription drugs sold in the state. The bill defines "excessive price increase" as an increase of more than 15% of the wholesale acquisition cost from the previous year or more than 40% from 3 years prior, adjusted for inflation. The bill also requires prescription drug manufacturers to maintain a registered agent in the state and provides the Attorney General with enforcement authority, including the ability to compel statements and records from manufacturers, issue orders to restrain violations, and impose civil penalties of up to $10,000 per day for each violation. Additionally, the bill prohibits manufacturers from withdrawing generic or off-patent drugs from sale in the state to avoid the price increase restrictions, with penalties of $500,000 for such withdrawal.

Committee Categories

Health and Social Services

Sponsors (9)

Last Action

Placed in Legislative Files (DEAD) (on 07/19/2021)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...